Quantcast
Channel: Modern medicine - Erin Bastick, PharmD, RPh
Browsing latest articles
Browse All 28 View Live

New therapies show promise in treating diabetes

View Article



How pharma reps impact physician prescribing

A new study led by The University of California researchers and published in JAMA reveals surprising findings.

View Article

Top 5 specialty drug management issues

The 13th edition EMD Serono Specialty Digest outlines top specialty drug management issues health plans face.

View Article

Combination pack approved for breast cancer treatment

FDA approves ribociclib plus letrozole to treat a subset of advanced breast cancer patients.

View Article

Drugmaker recalls samples of antiplatelet drug

AstraZeneca voluntarily recalls professional samples of its antiplatelet agent. Here's what to do.

View Article


Investigational drug appears beneficial in preventing migraines

Lilly's galcanezumab successful in three phase 3 migraine studies. Here are the findings.

View Article

Pharmaceutical pipeline: Top 4 conditions to watch

View Article

First generic Strattera for ADHD approved

FDA has approved the first generic versions of Strattera (atomoxetine) for the treatment of attention deficit/hyperactivity disorder.

View Article


Asthma biologic may reduce oral steroid use

A new trial for AstraZeneca’s benralizumab shows surprising results for severe asthma patients.

View Article


FDA gives once-daily HIV therapy go-ahead

FDA approves Isentress at a higher dose for HIV-1 infected patients.

View Article

FDA approves first generic Truvada for HIV

The first generic Truvada for treating and preventing HIV will be available, but when?

View Article

FDA approves EpiPen rival

Adamis’ epinephrine injection promises to be a lower-cost alterative to EpiPen.

View Article

FDA to drug maker: Pull opioid pain drug

Potential public health consquences prompts FDA to request removal of opioid pain medication.

View Article


Evolving hepatitis C pipeline offers hope to patients

Cost burden prompts payers to consider appropriate utilization

View Article

FDA approves Bayer’s Bluetooth-enabled auto-injector for multiple sclerosis

FDA has approved a supplemental Biologics License Application (sBLA) for Bayer’s myBETAapp and BETACONNECT Navigator for multiple sclerosis (MS) patients

View Article


New antibiotic approved for acute bacterial skin infections

FDA approved the use of a new fluoroquinolone antibiotic to treat ABSSI.

View Article

New universal companion diagnostic paves the way for precision oncology

FDA approves new diagnostic test for non-small cell lung cancer.

View Article


Popular insulin meets target in real-world study

Novo Nordisk’s DEVOTE study reveals interesting findings.

View Article

Brace for a barrage of biosimilars

The next few years will see the healthcare industry bracing itself for new biosimilar products for a range of illnesses from oncology to rheumatoid arthritis.

View Article

Oral specialty drug options on the horizon

As more specialty drugs are approved, cost control strategies are key.

View Article

Pediatric drug market poised for growth

View Article


Oncology treatments: Three areas to watch

While targeted cancer therapies make up a big part of the pipeline, there are three areas that oncology experts want you to keep on your radar.

View Article


Autoimmune drug pipeline highlights

View Article

Groundbreaking gene therapies in store for hemophilia

Treatment failures can result in a spectrum of problems for patients with hemophilia. Here’s some guidance on choosing the right therapy.

View Article

HIV pipeline prospects getting healthier

View Article

Browsing latest articles
Browse All 28 View Live




Latest Images